Hormonal modulation of the accumulation of 5-aminolevulinic acid- induced protoporphyrin and phototoxicity in prostate cancer cells

International Journal of Cancer

Volumn 72, Issue 6, 1997, Pages 1062-1069

  Momma, Tetsuo ^a,b   Hamblin, Michael R ^a   Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ANDROSTANOLONE; BENZOPORPHYRIN DERIVATIVE; DEFEROXAMINE MESYLATE; ESTRADIOL; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ARTICLE; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY;

AMINOLEVULINIC ACID; ANIMALS; BLOOD; CATTLE; CELL DIVISION; CELL SURVIVAL; CULTURE MEDIA; DIHYDROTESTOSTERONE; ESTRADIOL; HUMANS; KINETICS; MALE; PHOTOCHEMOTHERAPY; PROSTATIC NEOPLASMS; PROTOPORPHYRINS; TUMOR CELLS, CULTURED;

EID: 0030748941     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970917)72:6<1062::AID-IJC22>3.0.CO;2-5     Document Type: Article

References (35)

1. AVELINE, B., HASAN, T. and REDMOND, R.W., Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA). Photochem. Photobiol., 59, 328-335 (1994).
2. BERG, K., ANHOLT, H., BECH, O. and MOAN, J., The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells. Brit. J. Cancer, 74, 688-697 (1996).
3. CARRUBA, G., PFEFFER, U., FECAROTTA, E., COVIELLO, D.A., D'AMATO, E., LO CASTRO, M., VIDALI, G. and CASTAGNETTA, L., Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells. Cancer Res., 54, 1190-1193 (1994).
4. CASTAGNETTA, L.A., MICELI, M.D., SORCI, C.M., PFEFFER, U., FARRUGGIO, R., OLIVERI, G., CALABRO, M. and CARRUBA, G., Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinology, 136, 2309-2319 (1995).
5. CHANG, S.C., BUONACCORSI, G., MACROBERT, A. and BOWN, S.G., Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin. Int. J. Cancer, 67, 555-562 (1996).
6. CHARLESWORTH, P. and TRUSCOTT, T.G., The use of 5-aminolevulinic acid (ALA) in photodynamic therapy (PDT). J. Photochem. Photobiol. B, 18, 99-100 (1993).
7. DAMBER, J.E., BERGMAN, B., SODERGARD, R. and TOMIC, R., Binding capacity of testosterone-estradiol-binding globulin (TeBG), total and calculated unbound concentrations of testosterone in patients with carcinoma of the prostate treated with orchidectomy or estroaens. J. Endocrinol. Invest., 6, 91-94 (1983).
8. DARBRE, P., YATES, J., CURTIS, S. and KING, R.J.B., Effect of estradiol on human breast cancer cells in culture. Cancer Res., 43, 349-354 (1983).
9. DIETEL, W., BOLSEN, K., DICKSON, E., FRITSCH, C., POTTIER, R. and WENDENBURG, R., Formation of water-soluble porphyrins and protoporphyrin IX in 5-aminolevulinic-acid-incubated carcinoma cells. J. Photochem. Photobiol. B, 33, 225-231 (1996).
10. EBERT, P.S., HESS, R.A., FRYKHOLM, B.C. and TSCHUDY, D.P., Succinylacetone, a potent inhibitor of heme biosynthesis: effect on cell growth, heme content and d-aminolevulinic acid dehydratase activity of malignant murine erythroleukemia cells. Biochem. biophys. Res. Comm., 173, 534-540 (1979).
11. GOMER, C.J., Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem. Photobiol., 54, 1093-1107 (1991).
12. HASAN, T. and PARRISH, J.A., Photodynamic therapy of cancer. In: J.F. Holland, E.I. Frei, R.C.J. Bast, D.W. Kufe, D.L. Morton and R.R. Weichselbaum (eds.), Cancer Medicine, pp. 739-751, Williams and Wilkins, Baltimore, MD (1996).
13. HENDERSON, B.W. and DOUGHERTY, T.J., How does photodynamic therapy work? Photochem. Photobiol., 55, 145-157 (1992).
14. HENDERSON, B.W., VAUGHAN, L., BELLNIER, D.A., VAN LEENGOED, H., JOHNSON, P.G. and OSEROFF, A.R., Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin. Photochem. Photobiol., 62, 780-789 (1995).
15. HOROSZEWICZ, J.S., LEONG, S.S., KAWINSKI, E., KARR, J.P., ROSENTHAL, H., CHU, T.M., MIRAND, E.A. and MURPHY, G.P., LNCaP model of human prostatic carcinoma. Cancer Res., 43, 1809-1818 (1983).
16. HUA, Z., GIBSON, S.L., FOSTER, T.H. and HILF, R., Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res., 55, 1723-1731 (1995).
17. HUGGINS, S., Prostatic cancer treated by orchiectomy: the five year results J. amer. med. Ass., 131, 576-581 (1946).
18. IGUCHI, T., FUKAZAWA, Y., TANI, N., SATO, T., OZAWA, S., TAKASUGI, N., SHUIN, T., KUVOTAL, Y. and PETROV, V., Effect of some hormonally active steroids upon the growth of LNCaP human prostate tumor cells in vitro. Cancer J., 3, 184-191 (1990).
19. IINUMA, S., BACHOR, R., FLOTTE, T. and HASAN, T., Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J. Urol., 153, 802-806 (1995).
20. IINUMA, S., FARSHI, S.S., ORTEL, B. and HASAN, T., A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Brit. J. Cancer, 70, 21-28 (1994).
21. KENNEDY, J.C. and POTTIER, R.H., Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B, 14, 275-292 (1992).
22. KENNEDY, J.C., POTTIER, R.H. and PROSS, D.C., Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B, 6, 143-148 (1990).
23. LARSON, E., HOWLETT, B. and JAGENDORF, A., Artificial reductant enhancement of the Lowry method for protein determination. Anal. Biochem., 155, 243-248 (1986).
24. LEE, C., SUTKOWSKI, D.M., SENSIBAR, J.A., ZELNER, D., KIM, I., AMSEL, I., SHAW, N., PRINS, G.S. and KOZLOWSKI, J.M., Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology, 136, 796-803 (1995).
25. LOH, C.S., VERNON, D., MACROBERT, A.J., BEDWELL, J., BOWN, S.G. and BROWN, S.B., Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J. Photochem. Photobiol. B, 20, 47-54 (1993).
26. MILLER, D.L., EL-ASHRY, D., CHEVILLE, A.L., LIU, Y., MCLESKEY, S.W. and KERN, F.G., Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Differ., 5, 1263-1274 (1994).
27. PANTELIDES, M.L., WHITEHURST, C., MOORE, J.V., KING, T.A. and BLACKLOCK, N.J., Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland. J. Urol., 143, 398-401 (1990).
28. REDDEL, R.R., MURPHY, L.C. and SUTHERLAND, R.L., Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Cancer Res., 44, 2398-2405 (1984).
29. RITTENHOUSE-DIAKUN, K., VAN LEENGOED, H., MORGAN, J., HRYHORENKO, E., PASZKIEWICZ, G., WHITAKER, J.E. and OSEROFF, A.R., The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA). Photochem. Photobiol., 61, 523-528 (1995).
30. SELMAN, S.H., KECK, R.W. and HAMPTON, J.A., Transperineal photodynamic ablation of the canine prostate. J. Urol., 156, 258-260 (1996).
31. SONNENSCHEIN, C., OLEA, N., PASANEN, M.E. and SOTO, A.M., Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res., 49, 3474-3481 (1989).
32. VAN HILLEGERSBERG, R., VAN DEN BERG, J.W.O., KORT, W.J., TERPSTRA, O.T. and WILLSON, J.H.P., Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology, 103, 647-651 (1992).
33. VELDSCHOLTE, J., RIS-STALPERS, C., KUIPER, G.G., JENSTER, G., BERREVOETS, C., CLAASSEN, E., VAN ROOIJ, H.C., TRAPMAN, J., BRINKMANN, A.O. and MULDER, E., A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. biophys. Res. Comm., 173, 534-540 (1990).
34. WINDAHL, T., ANDERSSON, S.O. and LOFGREN, L., Photodynamic therapy of localised prostatic cancer. Lancet, 336, 1139 (1990).
35. XU, S., MENON, I.A., BECKER, M.A., WILTSHIRE, J.D., HABERMAN, H.F., CHEN, Z. and GASPARI, A.A., Endogenous porphyrins in murine skin and transplanted PAM-212 squamous cell carcinoma tissues after injection of delta-aminolevulinic acid. Chin. med. J., 108, 286-290 (1995).